Long-term Results of Papillary Thyroid Cancer Treatment and Comparative Analisis of Various Treatment Strategies
https://doi.org/10.14341/CET201410131-37
Abstract
There are discriminating approaches towards differentiated thyroid carcinomas due to their different prognoses according to the European, American and Japanese thyroid recommendations. Materials and Methods. We have analyzed data on 331 patients with papillary thyroid cancer, operated on during the period of 1966-2000 years. Mean observation period was 18.8 years, the maximum period of observation was 57 years.Results. Survival rate analysis after surgical treatment showed favourable prognosis for thyroid cancer patients, adjusted for that there was no ultrasonography and FNAB during those years, and patients had generally more progressive tumours. One of the most important factors for the prognosis of a patient is the size of a tumour at the moment of operation and presence of distant metastases. Long-term results of surgical treatment are practically independent of its extent (thyroidectomy or thyroid resection, prophylactic lymphodissection). Mortality and recurrence rates in patients who were not submitted to radioactive iodine treatment do not differ considerably from literature data.
About the Authors
R ChernikovPirogov National Medical & Surgical Center, Saint Petersburg, Russia
E Valdina
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
S Vorobjev
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
I Sleptsov
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia; Saint-Petersburg state university, medical faculty
A Semenov
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia; Saint-Petersburg state university, medical faculty
I Chinchuk
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
V Makarin
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
A Kuliash
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
A Uspenskaya
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
N Timofeeva
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
K Novokshonov
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
Iu Karelina
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia; Saint-Petersburg state university, medical faculty
E Fedorov
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
M Isheiskaia
Pirogov National Medical & Surgical Center, Saint Petersburg, Russia
Y Fedotov
Northern-western state Mechnicov medical university; Pirogov National Medical & Surgical Center; Saint Petersburg, Russia
A Bubnov
Northern-western state Mechnicov medical university; Saint-Petersburg state university, medical faculty; Pirogov National Medical & Surgical Center; Saint Petersburg, Russia
References
1. Watkinson JC. The British Thyroid Association guidelines for the management of thyroid cancer in adults. Nucl Med Commun. 2004 Sep;25(9):897-900.
2. Cooper D, Doherty G, Haugen B et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167-1213.
3. National Comprehensive Cancer Network (2010) NCCN clinical practice guidelines in oncology. Thyroid carcinoma. 2010;1.
4. Thyroid Carcinoma Task Force (2001) AACE/AAES medical/ surgical guidelines for clinical practice: management of thyroid carcinoma. Endocrinol Pract. 2001;7:202-220.
5. The Japanese Society of Thyroid Surgery/The Japanese Society of Endocrine Surgeons (2010) Guidelines for management of thyroid tumor. Kanehara Press, Tokyo.
6. Schlumberger M, Challeton C, De Vathaire F et al. Radioactive iodine treatment and external radiotherapy for lung and bone metastases from thyroid carcinoma. J Nucl Med. 1996;37(4): 598-605.
7. Lin JD, Huang MJ, Juang JH et al. Factors related to the survival of papillary and follicular thyroid carcinoma patients with distant metastases. Thyroid. 1999;9(12):1227-1235.
8. Durante C, Haddy N, Baudin E et al. Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy. J Clin Endocrinol Metab. 2006;91(8):2892-2899.
9. Das DK. Psammoma body: a product of dystrophic calcification or of a biologically active process that aims at limiting the growth and spread of tumor. Diagn Cytopathol. 2009;37(7):534-541.
10. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA. 2006;295(18):2179-2182.
11. Takebe K, Date M, Yamamoto Y et al. Mass screening for thyroid cancer with ultrasonography. Karkinos. 1994;7:309-317.
12. Ito Y, Miyauchi A, Inoue H et al. An observation trial for papillary thyroid microcarcinoma in Japanese patients. World J Surg. 2010;34:28-35.
13. Sugitani I, Toda K, Yamada N et al. Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes. World J Surg. 2010;34:1222- 1231.
14. DeLelis RA, Lloyd RV, Heitz PU, Eng C (Eds.). World Health Organisation Classification of Tumors. Pathology and Genetics of Tumors of Endocrine Organs. Lyon: IARC Press, 2004.
15. Colonna M, Bossard N, Guizard AV et al. Descriptive epidemiology of thyroid cancer in France: incidence, mortality and survival. Ann Endocrinol (Paris). 2010;71(2):95-101.
16. Reynolds RM, Weir J, Stockton DL et al. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf). 2005;62(2):156-162.
17. Бомаш Н.Ю. Морфологическая диагностика заболеваний щитовидной железы. М.: Медицина, 1981. 176 с.
Review
For citations:
, , , , , , , , , , , , , , , Long-term Results of Papillary Thyroid Cancer Treatment and Comparative Analisis of Various Treatment Strategies. Clinical and experimental thyroidology. 2014;10(1):31-37. (In Russ.) https://doi.org/10.14341/CET201410131-37
Views:
433
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND 4.0).
Email this article 
